Care, efficiency and financial benefits

Assessing risk for invidual patients, driving improved care and accruing financial savings

Spotlight on benefits in the UK (estimated figures)

Lives Saved

Harms avoided

million

Saved

Why our Ai-backed, risk adjusted results go beyond current approaches

Where quality is reported on the basis of mortality rates and readmissions, the true picture may be very different.

We understand and show the difference between unadjusted mortality and the true picture when case-mix and complexity of patients treated is taken into account.

In the diagram on the right, notice that in the period when overall mortality is at its highest (A), the case-mix adjusted quality is nevertheless good.

Points plotted below the yellow line represent better than predicted outcomes, benchmarked against international as well as UK practice.

Why hospitals trust our unique, risk-adjusted systems

Demonstrable reduction in harm and mortality

No matter the complication we have got you covered. In the UK alone we think we’ve contributed to saving 455 lives in the last year

Fewer readmissions

Not just improving care in the hospital but reducing 30 day readmissions

Significant savings

Averaged potential savings per hospital ~£2.3m per annum

Extensive and reliable

The system cannot be gamed like other approaches and covers all patients and the majority of procedures (146) and triggers (32).

Corporate Governance

Safeguarding quality and care in the hospital – while reducing management and board’s exposure to sanctions

Reduction in complaints and clinical negligence claims

Up to 10% in sampled hospital

Prospective assessments

Can quickly assess patients suitability for operation and their likely complications – allowing targeted care and reduction in harm/mortality

Drive down to root cause

The system can help you identify where issues are occurring and how to fix them

Benefits delivered by our approach and solutions

CARE BENEFITS

Demonstrable reduction in avoidable harm

Demonstrable reduction in mortality

Targets improvement efforts to right areas

Demonstrable performance and improvement tracking

Fewer readmissions

Properly risk-adjusted stats mean surgeons no longer ducking high risk ops for fear of “screwing up” their stats

Evidence to use with regulatory authorities (e.g. CQC) potentially leading to improved ratings

Better rankings

FINANCIAL BENEFITS

Significant savings on treatments and care related to avoidable harm (e.g. £2.3m per annum possible – average across three UK hospitals)

Lower complaints & clinical negligence claims (down ~10%)

Reduced legal costs

Reduction in cost per treatment and variations

Lower readmission rates (which are subject to financial penalties in a number of countries)

RoI on our system 30 – 40x

Option to deploy at zero up front cost and % share of savings identified

Lower variability in treatment costs

Reduction in insurance premiums – at individual practitioner and hospital level

Higher margins against fixed price per treatment

EFFICIENCY BENEFITS

Better use of resources due to reduction in beds blocked (esp. critical care) through additional, avoidable care and readmissions

More effective use of resources in the hospital by avoiding harms

Less management overhead used up fixing issues and dealing with problems

Identify avoidable use of HDU/ITU

Identify issues with return to theatre/unnecessary surgery and equipment usage